Biotech · Public company · South San Francisco, CA, US
Pliant Therapeutics, Inc.
Ticker PLRX · SEC CIK 0001746473
Track this companyFree. Adds Pliant Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials81 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline5
- Knottin tracerPhase 2 · Idiopathic Pulmonary FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- PLN-74809Phase 2 · Acute Respiratory Distress SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- PLN-74809Phase 2 · Idiopathic Pulmonary FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- PLN-74809Phase 2 · Primary Sclerosing CholangitisClinicalTrials.gov · fetched Nov 12, 2026
- PLN-101095Phase 1 · Advanced or Metastatic Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary FibrosisPHASE2 · TERMINATED · started Nov 16, 2023ClinicalTrials.gov NCT06097260 · fetched Nov 12, 2026
- A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid TumorsPHASE1 · RECRUITING · started Aug 30, 2023ClinicalTrials.gov NCT06270706 · fetched Nov 12, 2026
- Imaging Evaluation of PLN-74809 in Participants With IPF (PLN-74809)PHASE2 · COMPLETED · started Jul 13, 2022ClinicalTrials.gov NCT05621252 · fetched Nov 12, 2026
- Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19PHASE2 · TERMINATED · started Oct 22, 2020ClinicalTrials.gov NCT04565249 · fetched Nov 12, 2026
- Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC)PHASE2 · COMPLETED · started Jul 27, 2020ClinicalTrials.gov NCT04480840 · fetched Nov 12, 2026
- Evaluation of Efficacy and Safety of PLN-74809 in Patients With Idiopathic Pulmonary FibrosisPHASE2 · COMPLETED · started Mar 3, 2020ClinicalTrials.gov NCT04396756 · fetched Nov 12, 2026
- Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF/PHASE2 · COMPLETED · started Feb 13, 2020ClinicalTrials.gov NCT04072315 · fetched Nov 12, 2026
- Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CTEARLY_PHASE1 · COMPLETED · started Nov 8, 2017ClinicalTrials.gov NCT03183570 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Aug 11, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 11, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 17, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 30, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 11, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 3, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Dec 16, 2025 · fetched Nov 12, 2026